CC 240927 20.00C (CC240927C20000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CC240927C20000

Watchlist

0.75
-0.05-6.25%

15min DelayClose Sep 27 16:00 ET

1.15High0.75Low

Intraday

5D
Daily

News

Navigating 7 Analyst Ratings For Chemours
BenzingaSep 25 12:00 ET · Ratings
Chemours Is Maintained at Equal-Weight by Barclays
Dow JonesSep 25 11:49 ET · Ratings
Take Care Before Diving Into The Deep End On The Chemours Company (NYSE:CC)
Simply Wall StSep 25 09:35 ET
Chemours (NYSE:CC) Investors Are up 5.8% in the Past Week, but Earnings Have Declined Over the Last Five Years
Yahoo FinanceSep 25 07:31 ET
Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $21
Moomoo NewsSep 25 05:33 ET · Ratings
Express News | Chemours : Barclays Cuts Target Price to $21 From $22
ReutersSep 25 05:29 ET

Comments

SpyderCall

Jun 6 05:57

This turned out to be a great short, so far.

$The Chemours (CC.US)$
$SPDR S&P 500 ETF (SPY.US)$

SpyderCall: Options Action in This Ticker was Skewed Heavily on the Bearish Side Today

SpyderCall

May 30 11:00

Options Action in This Ticker was Skewed Heavily on the Bearish Side Today

$The Chemours (CC.US)$
Unusual Options Activity
There was an unusual amount of activity on the options chain for The Chemours company. Most of the activity was on the put side. You can see this in the heavily skewed put to call ratio in the picture directly below. A lopsided put/call ratio like this doesn't show the full picture. We need to find out if the puts were bought or sold to know if the activity was bullish or bear...

Dow tops 40,000 for the first time: Will the U.S. market rally march on?

Movers and Shakers

Mar 28 20:32

Columns Today's Morning Movers and Top Ratings: EL, BAC, ALL, RH and More

Morning Movers
Gapping up
$Estee Lauder (EL.US)$ Shares soared over 3% following an upgrade to buy from neutral by Bank of America, which referenced the company's profitability recovery efforts, new products, and growing market share in the prestige beauty sector.
$Allstate (ALL.US)$ The insurance stock climbed 0.9% after HSBC raised its rating to buy from hold, with analyst Vikram Gandhi commending the company's "decisive management...

Moomoo AI

Mar 28 07:02

The revelation of material weaknesses in Chemours' financial reporting and the manipulation of vendor payments and receivables by top executives could negatively impact investor confidence and the company's stock price.

Chemours Finds Material Weaknesses After Internal Review, Stock Slumps ~11% After Hours

Moomoo AI

Mar 28 05:49

Chemours' ongoing investigation and executive suspension could hurt investor confidence and stock price, despite a narrower Q4 loss and higher revenue.

Chemours Responds to Regulators, Prosecutors About Internal Audit